Bioventix Share Discussion Threads

[suetballs] 26/9/2022 08:59

Thought weak sterling would give this a boost this am.
Suet

[doctor888] 15/9/2022 11:51

@stepone68 - thanks for that - great work!

[stepone68] 15/9/2022 10:51

Well, because I've got nothing better to do, I looked back at previous updates. The last one, as mentioned above, was 2017 !

In it, they said, "revenues for the financial year ended 30 June 2017 are expected to be marginally in excess of £7M (2015/16: £5.5M). Since the cost-base of the Company continues to follow a similar shallow trajectory as in previous years, both revenues and profits before tax are expected to be ahead of market expectations for the year ended 30 June 2017"

So, they actually gave a figure for turnover there! Looking at my notes, forecasts in 2017 were saying revenues of 6.3m. After the update, forecasts were showing 7.06m. The actual came in at 7.25m. So that looks like a bit over 10% to me, and they only said 'ahead' (i.e. no mention of 'materially' or 'significantly').

In August 2016 they also gave a revenue number - "in excess of 5.3m", and once again simply said profits would be "ahead". Forecasts had been saying £4.8m. So, again it looks like they were about 10% ahead, and, in the end, turnover was £5.5m.

In both those years, though, the high margins meant that EPS was 30-40% above forecasts.

This year, they did use the word 'significantly', so we should surely expect at least 10%, if not more! So, I'm going to take a punt on 11.4m turnover, eps 150p, dividend 150p - and I'm actually hoping for slightly more!!

Fingers crossed,
StepOne

[alter ego] 14/9/2022 22:28

I’ve always regarded the words “materially221; and “significantly” as meaning more than 10% and more than 20% fwiw

[doctor888] 14/9/2022 18:26

It is very likely to be a record revenue for a 6 month period, but as you say, it is anyone's guess. Has anyone trawled through prior RNS to see what 'significantly ahead' suggests?

[podgyted] 14/9/2022 18:22

I suspect over £11m.

(Why do companies keep on saying significantly/materially/exceeding - just tell us the revenue number - we're not financially illiterate as opposed, seemingly, to the entire of the City.)

Unhelpfully finnCap have not updated their forecasts this morning - they are still showing £10.4m - so significantly ahead would lead me to at least £11m.

[stepone68] 14/9/2022 13:23

Anyone care to guess what the sales might be? I've not recorded any forecasts for a couple of years, since Sharecast stopped publishing them. I found some today on marketscreener.com which say 10.4m for the year ended in June. 6 months to end December was 4.73m, which means market expecting 5.7 for H2. Can we add 0.5m for out-performance, and possibly another 0.5 for exchange rate headwind, to get us somewhere over 11m?

Maybe it doesn't matter that much and the main thing will be Troponin performance and pipeline progress.

[igbertsponk] 14/9/2022 09:56

Such a well run company. Bravo!

[jurgenklopp] 14/9/2022 09:10

Imagine if the RNS came out on a positive day for the general market !!!

Roll on October 24.

[trident5] 14/9/2022 08:52

That's the first update they've put out in the last 5 years.

[suetballs] 14/9/2022 07:30

Good trading update:

- fy2022 trading is likely to be signifcantly ahead of market expectations.
- hope that this recovery will be sustained and long lasting.
- 50% of revenues are in US$ with favourable exchange rates.

Nice to have some good news!!
Suet

[redartbmud] 30/3/2022 16:15

Is that animal, vegetable or mineral?
Are yoy born with it, can you develop it or do you need to buy it?

[boros10] 30/3/2022 15:48

It's all down to the "Tau" of Peter Harrison

[igbertsponk] 30/3/2022 14:38

Good reaction after disappointing results. The Company still trusted it seems.

[suetballs] 28/3/2022 10:03

Oops - well they are scientists!
Suet

[piedro] 28/3/2022 09:21

Interims ...

"Board is pleased to announce a first interim dividend of 52p per share which represents a 20% increase on the interim dividend paid last year (43 pence per share). The shares will be marked ex-dividend on the 7 April 2021 and the dividend will be paid on 22 April 2021 to shareholders on the register at close of business on 8 April 2021."

!!

[doctor888] 15/3/2022 08:52

Good news for our investment. Perhaps a catalyst for the share price Looking forward to results.

hxxps://www.bioworld.com/articles/516919-cardinor-secures-ce-mark-for-cardiovascular-risk-test?v=preview

[stepone68] 20/1/2022 12:10

John, you were predicting a tenner 2 years ago. You might be right eventually, but not yet :-)

[suetballs] 24/11/2021 15:35

Yep - almost every company carries a covid health warning - not unexpected surely.
Suet

[onjohn] 24/11/2021 14:35

The core business is linked to routine testing at hospitals around the world and this has undoubtedly been affected by the COVID-19 pandemic. The timing of a return to normality is uncertain


From last rns

Not pleasing

[igbertsponk] 24/11/2021 14:06

LOL - get back to Staffline - hot your 140p target yet?

[onjohn] 24/11/2021 14:01

Lack of diagnosis due to covid will reduce prescribing and hence profit warning

Profit warn will not be taken well

[stepone68] 24/11/2021 13:49

Can't see it crashing 50% in a day either. Demand for healthcare is only going to increase and the approvals regimes mean long windows of opportunity.